Session One - Diabetes MDT
| Saturday, May 30, 2026 |
Overview
SESSION CHAIR: Deborah Hawthorne
Details
3 back-to-back sessions focusing on diabetes and MDT care.
Learning Objectives:
• Describe the mechanisms linking type 2 diabetes with progressive kidney dysfunction.
• Discuss when pharmacotherapy may be recommended to help preserve kidney function in people living with type 2 diabetes.
• Describe the role of a pharmacist CDE in primary health care settings
• Identify multidisciplinary team models that support comprehensive type 2 diabetes management
• Recognise challenges in delivering person-centred care for people living with type 2 diabetes
Competency Standards (2016): 1.6, 2.4 3.1, 3.5, 3.6